Non-Alcoholic Steatohepatitis: Opportunities in a Growing Market

Mohammad Uddin, MSc is an Analyst on the Immunology team at GlobalData in London. He is responsible of delivering research and analysis content for respiratory disease areas, including IPF, SSc, and related interstitial lung diseases. He also offers support on other diseases such as RSV, influenza, and NASH. Before joining GlobalData, Mohammad worked as a Business Development Associate at Decision Resources Group. Mohammad holds an MSc in Drug Discovery and Pharmaceutical Management and a BSc in Biomedical Science.

Kasey Fu, MPH, is the Director of Epidemiology at GlobalData in Boston, where her primary responsibilities include producing descriptive and analytical epidemiological reports for major drug indications, monitoring and maintaining the company’s state-of-the-art epidemiology database, liaising with other company units in developing new products, and completing global consulting projects. Prior to joining GlobalData, Kasey worked as a Wilbur G. Downs Global Health Fellow at the Instituto Nacional de Salud of Colombia analyzing dengue epidemic trends, risk factors, and the effects of climate change using multivariate regression and spatial modeling. She also worked as a staff writer for the Yale-Tulane Virtual Medical Operations Center producing public health and epidemiology reports for US military operations and international aid efforts during catastrophic disasters. Kasey holds a Master of Public Health in the Epidemiology of Microbial Diseases from the Yale School of Public Health. She is also fluent in Chinese and proficient in Spanish.

Tina Healy, MSci, is the Vice President of Disease Analysis and Intelligence at GlobalData. Prior to this role, Tina was a Senior Director and managed the Immunology and Neurology market analysis and forecasts portfolios and GlobalData’s syndicated Competitive Intelligence (CI) portfolio. Tina has over nine years’ experience in pharmaceutical market intelligence, three years’ experience in drug discovery, and a proven track record of disease and competitive analysis. Prior to her roles at GlobalData, Tina was an Engagement Manager with consulting firm Lifescience Dynamics, covering CI deep-dive and monitoring projects, MR and MA projects. Prior to joining Lifescience Dynamics, Tina was the Director for Immunology at GlobalData, where she managed the production of syndicated reports, product forecasts, and analyses in autoimmune diseases. Tina has also held several Analyst roles at GlobalData and at Datamonitor, covering Immunology-Inflammation, where she authored numerous in-depth analyses of products and companies, bespoke client deliverables, and produced sales- and patient-based indication-specific forecasts. Before joining Datamonitor, Tina worked as a research scientist within GSK’s drug discovery medicinal chemistry unit. Prior to that role, she worked within the early drug development unit at Evotec, a drug-discovery alliance and development partnership company. Tina holds a Master’s degree in Medicinal Chemistry from University College London.